(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | 28.34%102.63M | 30.80%174.42M | 86.34%79.97M | 112.35%133.35M | --42.92M | 76.22%62.8M | --35.64M |
Operating income | 28.34%102.63M | 30.80%174.42M | 86.34%79.97M | 112.35%133.35M | 42.92M | 76.22%62.8M | 35.64M |
Operating expenses | |||||||
Gross profit | |||||||
Selling expenses | -16.86%-34.64M | -54.56%-62.48M | -61.31%-29.64M | -47.47%-40.43M | ---18.37M | -60.54%-27.41M | ---17.08M |
Administrative expenses | -131.62%-234.31M | -44.81%-295.99M | -15.18%-101.17M | -49.16%-204.4M | ---87.83M | -188.58%-137.04M | ---47.49M |
Research and development expenses | 10.25%-210.39M | -33.91%-480.66M | -46.81%-234.42M | -68.84%-358.95M | ---159.68M | -154.50%-212.6M | ---83.54M |
Impairment and provision | -159.62%-270K | 75.17%-217K | ---104K | -29.87%-874K | ---- | 76.20%-673K | ---2.83M |
-Other impairment is provision | -159.62%-270K | 75.17%-217K | ---104K | -29.87%-874K | ---- | 76.20%-673K | ---2.83M |
Special items of operating profit | 89.39%-15.88M | -6.24%-57.38M | -550.92%-149.63M | -448.63%-54.01M | ---22.99M | 240.46%15.49M | ---11.03M |
Operating profit | 9.69%-392.86M | -37.50%-722.31M | -76.86%-434.99M | -75.44%-525.31M | -245.96M | -137.04%-299.43M | -126.32M |
Financing income | -28.20%36.41M | 103.44%102.69M | 852.77%50.72M | 259.15%50.48M | --5.32M | 143.50%14.06M | --5.77M |
Financing cost | 2.94%-3.73M | -66.64%-9.58M | -30.68%-3.85M | -60.73%-5.75M | ---2.94M | -378.58%-3.58M | ---747K |
Special items of earning before tax | -277.89%-877.37M | -33.31%-1.28B | -132.19%-232.18M | 48.17%-958.04M | ---99.99M | -201.50%-1.85B | ---613.06M |
Earning before tax | -99.51%-1.24B | -32.51%-1.91B | -80.54%-620.3M | 32.69%-1.44B | -343.57M | -191.05%-2.14B | -734.36M |
After-tax profit from continuing operations | -99.51%-1.24B | -32.51%-1.91B | -80.54%-620.3M | 32.69%-1.44B | -343.57M | -191.05%-2.14B | -734.36M |
Earning after tax | -99.51%-1.24B | -32.51%-1.91B | -80.54%-620.3M | 32.69%-1.44B | -343.57M | -191.05%-2.14B | -734.36M |
Minority profit | 92.68%-534K | 7,428.18%8.06M | -18,127.50%-7.29M | -150.00%-110K | ---40K | 82.40%-44K | ---250K |
Profit attributable to shareholders | -101.80%-1.24B | -33.08%-1.91B | -78.44%-613.01M | 32.69%-1.44B | -343.53M | -191.14%-2.14B | -734.11M |
Basic earnings per share | -33.86%-1.7 | -33.33%-3.96 | -78.87%-1.27 | 32.96%-2.97 | -0.71 | -189.54%-4.43 | -1.53 |
Diluted earnings per share | -33.86%-1.7 | -33.33%-3.96 | -78.87%-1.27 | 32.96%-2.97 | -0.71 | -189.54%-4.43 | -1.53 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data